Nature Methods Publication Reveals Deep Insights into Functional Biology through First-of-its-Kind Quantification of Tau ProteoformsUnusual Whales·23 hours agoNAUT-1.59%
PMGC Holdings Amends YuvaBio Development and License Deal to Launch Three-Phase Expansion ProgramTradingView·2 days ago, 09:13 PM
Telix Pharmaceuticals shares are trading higher after HC Wainwright & Co. reiterated its Buy rating on the stock and maintained a $20 price target.benzinga_article·2 days ago, 02:53 PMTLX+1.70%
NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic ApplicationsUnusual Whales·Sep 1 at 11:46 AM
“We’re not doing 30 bets a year”: Vijay Pande on betting small after running $4 billion at a16zTechCrunch·Aug 29 at 05:38 PMBIB-1.57%BIS+1.60%
GeneDx - CW27 | 10-Q: FY2025 Q3 Revenue: USD 116.74 MEarnings Watch·Oct 28, 2025 at 10:53 AMWGSWW0.00%
GeneDx - CW27 | 8-K: FY2025 Q3 Revenue: USD 116.74 MEarnings Watch·Oct 28, 2025 at 10:45 AMWGSWW0.00%
GeneDx - CW27 | 10-Q: FY2025 Q2 Revenue: USD 102.69 MEarnings Watch·Jul 29, 2025 at 12:22 PMWGSWW0.00%
GeneDx - CW27 | 8-K: FY2025 Q2 Revenue: USD 102.69 MEarnings Watch·Jul 29, 2025 at 11:22 AMWGSWW0.00%
GeneDx - CW27 | 10-Q: FY2025 Q1 Revenue: USD 87.12 MEarnings Watch·Apr 30, 2025 at 11:06 AMWGSWW0.00%
